Skip to main content
Erschienen in: Medical Oncology 4/2011

01.12.2011 | Original Paper

A clinicopathological study of resected non-small cell lung cancers 2 cm or less in diameter: a prognostic assessment

verfasst von: Chun-Lei Shi, Xue-Yan Zhang, Bao-Hui Han, Wei-Zhong He, Jie Shen, Tian-Qing Chu

Erschienen in: Medical Oncology | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

The detection and diagnosis of small-sized (2 cm or less) non-small cell lung cancer (NSCLC) has increased with the development of computed tomography (CT). Over 80% of 5-year survival rate has been reported in surgically treated peripheral lung cancer. There are systematic mediastinal and hilar lymph node involvement pleural invasion and intrapulmonary metastasis even with tumor diameter less than 2 cm. The appropriate surgical procedure for such kinds of lung cancer is lobectomy with mediastinal lymph node dissection. To evaluate the prognostic factors and establish the optimal surgical strategy, we analyzed the clinicopathologic features and survival benefit in different tumor size of peripheral small-sized NSCLC. Among the resected lung cancer cases between January 1999 and July 2001, 185 patients were retrospectively analyzed in surgical methods, lymph node involvement, CT scan findings and survival rates. Survival was analyzed by Kaplan–Meier method and log-rank test. Lymph node involvement was recognized in 26(14.05%) patients. There was no statistically significant difference in the incidence of lymph node involvement between tumors 1.6–2.0 cm (17.82%) in diameter than in those 1.0–1.5 cm (11.94%). There was no lymph node metastasis in tumors less than 1.0 cm in diameter. The 5-year survival rates with or without lymph node involvement were 89.98 and 46.15%, respectively, showing significant difference (P = 0.000). The overall 5-year survival rate was 83.78%. The 5-year survival rate in tumors 1.6–2.0 cm, 1.0–1.5 cm and less than 1.0 cm in diameter was 80.20, 85.07 and 100%, respectively, and showing significant difference(P = 0.035). The 5-year survival rate of 19 patients showing ground-glass opacity (GGO) on CT scan was 94.74% without any metastasis and recurrence after operation. There are systematic mediastinal and hilar lymph node involvement even with tumor diameter less than 2 cm. The results of the present study suggested that systematic lymph node dissection is necessary even for cases with tumor diameter less than 2 cm. However, if the tumor is within 1.0 cm in diameter with obvious GGO showing on chest CT scan, these are good candidates for partial resection without mediastinal lymph node dissection.
Literatur
2.
Zurück zum Zitat Arifa P, Pieter EP, Thomas GS. What is early lung cancer? A review of the literature. Lung cancer. 2004;45:267–77.CrossRef Arifa P, Pieter EP, Thomas GS. What is early lung cancer? A review of the literature. Lung cancer. 2004;45:267–77.CrossRef
3.
Zurück zum Zitat Ginsberg RJ (2002) Role of surgery in the treatment of stage I and II lung cancer. American Society of Clinical Oncology 2002. Educational book. Thirty-Eight Annual Meeting. May 18–21, 2002, Orlando FL, 460–464. Ginsberg RJ (2002) Role of surgery in the treatment of stage I and II lung cancer. American Society of Clinical Oncology 2002. Educational book. Thirty-Eight Annual Meeting. May 18–21, 2002, Orlando FL, 460–464.
4.
Zurück zum Zitat Park BJ, Altorki NK. Diagnosis and management of early lung cancer. Surg Clin North Am. 2002;82(3):457–76.PubMedCrossRef Park BJ, Altorki NK. Diagnosis and management of early lung cancer. Surg Clin North Am. 2002;82(3):457–76.PubMedCrossRef
5.
Zurück zum Zitat Birring SS, Peake MD. Symptoms and the early diagnosis of lung cancer. Thorax. 2005;60:268–9.PubMedCrossRef Birring SS, Peake MD. Symptoms and the early diagnosis of lung cancer. Thorax. 2005;60:268–9.PubMedCrossRef
6.
Zurück zum Zitat Henschke CI, Yankelevitz DF. CT screening for lung cancer: update 2007. Oncologist. 2008;13:65–78.PubMedCrossRef Henschke CI, Yankelevitz DF. CT screening for lung cancer: update 2007. Oncologist. 2008;13:65–78.PubMedCrossRef
7.
Zurück zum Zitat Cassidy A, Duffy SW, Myles JP, et al. Lung cancer risk prediction: a tool for early detection. Int J Cancer. 2007;120:1–6.PubMedCrossRef Cassidy A, Duffy SW, Myles JP, et al. Lung cancer risk prediction: a tool for early detection. Int J Cancer. 2007;120:1–6.PubMedCrossRef
8.
Zurück zum Zitat Watanabe T, Okada A, Imakiire T. Intentional limited resection for small peripheral lung cancer based on intraoperative pathologic exploration. Jpn J Thorac Cardiovasc Surg. 2005;53:29–35.PubMedCrossRef Watanabe T, Okada A, Imakiire T. Intentional limited resection for small peripheral lung cancer based on intraoperative pathologic exploration. Jpn J Thorac Cardiovasc Surg. 2005;53:29–35.PubMedCrossRef
9.
Zurück zum Zitat Konaka C, Ikeda N, Hiyoshi T, et al. Peripheral non-small cell lung cancers 2.0 cm or less in diameter: proposed criteria for limited pulmonary resection based upon clinicopathological presentation. Lung Cancer. 1998;21:185–91.PubMedCrossRef Konaka C, Ikeda N, Hiyoshi T, et al. Peripheral non-small cell lung cancers 2.0 cm or less in diameter: proposed criteria for limited pulmonary resection based upon clinicopathological presentation. Lung Cancer. 1998;21:185–91.PubMedCrossRef
10.
Zurück zum Zitat Watanabe S, Oda M, Go T, et al. Should mediastinal nodal dissection be routinely undertaken in patients with peripheral small-sized (2 cm or less) lung cancer? Retrospective analysis of 225 patients. Eur J Cardiothorac Surg. 2001;20:1007–11.PubMedCrossRef Watanabe S, Oda M, Go T, et al. Should mediastinal nodal dissection be routinely undertaken in patients with peripheral small-sized (2 cm or less) lung cancer? Retrospective analysis of 225 patients. Eur J Cardiothorac Surg. 2001;20:1007–11.PubMedCrossRef
11.
Zurück zum Zitat Swanson SJ, Batirel HF. Video-assisted thoracic surgery (VATS) resection for lung cancer. Surg Clin North Am. 2002;82(3):541–59.PubMedCrossRef Swanson SJ, Batirel HF. Video-assisted thoracic surgery (VATS) resection for lung cancer. Surg Clin North Am. 2002;82(3):541–59.PubMedCrossRef
12.
Zurück zum Zitat Shennib H, Bogart J, Herndon JE, Kohman L, Keenan R, Green M, et al. Video-assisted wedge resection and local radiotherapy for peripheral lung cancer in high-risk patients: the cancer and leukemia group B (CALGB) 9335, a phase II, multi-institutional cooperative group study. J Thorac Cardiovasc Surg. 2005;129:813–8.PubMedCrossRef Shennib H, Bogart J, Herndon JE, Kohman L, Keenan R, Green M, et al. Video-assisted wedge resection and local radiotherapy for peripheral lung cancer in high-risk patients: the cancer and leukemia group B (CALGB) 9335, a phase II, multi-institutional cooperative group study. J Thorac Cardiovasc Surg. 2005;129:813–8.PubMedCrossRef
13.
Zurück zum Zitat Rusch VW. High-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung[J]. J Thorac Cardiovasc Surg. 2002;124:221–2.PubMedCrossRef Rusch VW. High-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung[J]. J Thorac Cardiovasc Surg. 2002;124:221–2.PubMedCrossRef
14.
Zurück zum Zitat Ohtsuka T, Watanabe K, Kaji M, et al. A clinicopathological study of resected pulmonary nodules with focal pure ground-glass opacity. Eur J Cardiothorac Surg. 2006;30:160–3.PubMedCrossRef Ohtsuka T, Watanabe K, Kaji M, et al. A clinicopathological study of resected pulmonary nodules with focal pure ground-glass opacity. Eur J Cardiothorac Surg. 2006;30:160–3.PubMedCrossRef
16.
Zurück zum Zitat Sobue T, Moriyama N, Kaneko M, et al. Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J Clin Oncol. 2002;20:911–20.PubMedCrossRef Sobue T, Moriyama N, Kaneko M, et al. Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J Clin Oncol. 2002;20:911–20.PubMedCrossRef
17.
Zurück zum Zitat Koike T, Yamato Y, Yoshiya K, et al. Criteria for intentional limited pulmonary resection in cT1N0M0 peripheral lung cancer. Jpn J Thorac Cardiovasc Surg. 2003;51:515–9.PubMedCrossRef Koike T, Yamato Y, Yoshiya K, et al. Criteria for intentional limited pulmonary resection in cT1N0M0 peripheral lung cancer. Jpn J Thorac Cardiovasc Surg. 2003;51:515–9.PubMedCrossRef
18.
Zurück zum Zitat Nakamura H, Saji H, Ogata A, et al. Lung cancer patients showing pure ground-glass opacity on computed tomography are good candidates for wedge resection. Lung Cancer. 2004;44:61–8.PubMedCrossRef Nakamura H, Saji H, Ogata A, et al. Lung cancer patients showing pure ground-glass opacity on computed tomography are good candidates for wedge resection. Lung Cancer. 2004;44:61–8.PubMedCrossRef
19.
Zurück zum Zitat Matsuguma H, Yokoi K, Anraku M, et al. Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung a predictor of lymph node metastasis. J Thorac Cardiovasc Surg. 2002;124:278–84.PubMedCrossRef Matsuguma H, Yokoi K, Anraku M, et al. Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung a predictor of lymph node metastasis. J Thorac Cardiovasc Surg. 2002;124:278–84.PubMedCrossRef
20.
Zurück zum Zitat Nakata M, Sawada S, Saeki H, et al. Prospective study of thoracoscopic limited resection for ground-glass opacity selected by computed tomography. Ann Thorac Surg. 2003;75:1601–5.PubMedCrossRef Nakata M, Sawada S, Saeki H, et al. Prospective study of thoracoscopic limited resection for ground-glass opacity selected by computed tomography. Ann Thorac Surg. 2003;75:1601–5.PubMedCrossRef
21.
Zurück zum Zitat Ginsberg RJ, Rubinstein LV, Lung Study Group. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Ann Thorac Surg. 1995;60:615–23.PubMedCrossRef Ginsberg RJ, Rubinstein LV, Lung Study Group. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Ann Thorac Surg. 1995;60:615–23.PubMedCrossRef
22.
Zurück zum Zitat Patz EF, Rossi S, Harpole DH, et al. Correlation of tumor size and survival in patients with stage IA non-small cell lung cancer. Chest. 2000;117:1568–71.PubMedCrossRef Patz EF, Rossi S, Harpole DH, et al. Correlation of tumor size and survival in patients with stage IA non-small cell lung cancer. Chest. 2000;117:1568–71.PubMedCrossRef
23.
Zurück zum Zitat Pasic A, Postmus PE, Sutedja TG. What is early lung cancer? A review of the literature. Lung Cancer. 2004;45:267–77.PubMedCrossRef Pasic A, Postmus PE, Sutedja TG. What is early lung cancer? A review of the literature. Lung Cancer. 2004;45:267–77.PubMedCrossRef
24.
Zurück zum Zitat Detterbeck FC, Boffa DJ, Tanoue LT. The new lung cancer staging system. Chest. 2009;136:260–71.PubMedCrossRef Detterbeck FC, Boffa DJ, Tanoue LT. The new lung cancer staging system. Chest. 2009;136:260–71.PubMedCrossRef
25.
Zurück zum Zitat Suzuki K, Nagai K, Yoshida J, et al. Predictors of lymph node and intrapulmonary metastasis in clinical stage IA non-small cell lung carcinoma. Ann Thorac Surg. 2001;72:352–6.PubMedCrossRef Suzuki K, Nagai K, Yoshida J, et al. Predictors of lymph node and intrapulmonary metastasis in clinical stage IA non-small cell lung carcinoma. Ann Thorac Surg. 2001;72:352–6.PubMedCrossRef
26.
Zurück zum Zitat Fukui T, Mori S, Yokoi K, et al. T significance of the number of positive lymph nodes in resected non-small cell lung cancer. J Thorac Oncol. 2006;1:120–5.PubMedCrossRef Fukui T, Mori S, Yokoi K, et al. T significance of the number of positive lymph nodes in resected non-small cell lung cancer. J Thorac Oncol. 2006;1:120–5.PubMedCrossRef
27.
Zurück zum Zitat Hung JJ, Wang CY, Huang MH, et al. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival. J Thorac Cardiovasc Surg. 2007;134:638–43.PubMedCrossRef Hung JJ, Wang CY, Huang MH, et al. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival. J Thorac Cardiovasc Surg. 2007;134:638–43.PubMedCrossRef
28.
Zurück zum Zitat Miller DL, Rowland CR, Deschamps C, et al. Surgical treatment of non-small cell lung cancer 1 cm or less in diameter. Ann Thorac Surg. 2002;73:1545–51.PubMedCrossRef Miller DL, Rowland CR, Deschamps C, et al. Surgical treatment of non-small cell lung cancer 1 cm or less in diameter. Ann Thorac Surg. 2002;73:1545–51.PubMedCrossRef
29.
Zurück zum Zitat Takizawa T, Terashima M, Koike T, et al. Lymph node metastasis in small peripheral adenocarcinoma of the lung [J]. J Thorac Cardiovasc Surg. 1998;116:276–80.PubMedCrossRef Takizawa T, Terashima M, Koike T, et al. Lymph node metastasis in small peripheral adenocarcinoma of the lung [J]. J Thorac Cardiovasc Surg. 1998;116:276–80.PubMedCrossRef
30.
Zurück zum Zitat Kim BT, Kim Y, Lee KS, et al. Localized form of bronchioloalveolar carcinoma. AJR. 1998;170:935–9.PubMed Kim BT, Kim Y, Lee KS, et al. Localized form of bronchioloalveolar carcinoma. AJR. 1998;170:935–9.PubMed
31.
Zurück zum Zitat Nakajima R, Yokose T, Kakinuma R, et al. Localized pure ground-glass opacity on high-resolution CT: histologic characteristics. J Comput Assist Tomogr. 2002;26:323–9.PubMedCrossRef Nakajima R, Yokose T, Kakinuma R, et al. Localized pure ground-glass opacity on high-resolution CT: histologic characteristics. J Comput Assist Tomogr. 2002;26:323–9.PubMedCrossRef
32.
Zurück zum Zitat Kodama K, Higashiyama M, Yokouchi H, et al. Natural history of pure ground-glass opacity after long-term follow-up of more than 2 years. Ann Thorac Surg. 2002;73:386–93.PubMedCrossRef Kodama K, Higashiyama M, Yokouchi H, et al. Natural history of pure ground-glass opacity after long-term follow-up of more than 2 years. Ann Thorac Surg. 2002;73:386–93.PubMedCrossRef
33.
Zurück zum Zitat Aoki T, Nakata H, Watanabe H, et al. Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling time. AJR. 2000;174:763–8.PubMed Aoki T, Nakata H, Watanabe H, et al. Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling time. AJR. 2000;174:763–8.PubMed
34.
Zurück zum Zitat Yamato Y, Tsuchida M, Watanabe T, et al. Early resection for brochioloalveolar adenocarcinoma of the lung. Ann Thorac Surg. 2001;71:971–4.PubMedCrossRef Yamato Y, Tsuchida M, Watanabe T, et al. Early resection for brochioloalveolar adenocarcinoma of the lung. Ann Thorac Surg. 2001;71:971–4.PubMedCrossRef
35.
Zurück zum Zitat Yoshida J, Nagai K, Yokose T, et al. Limited resection trial of pulmonary ground-glass opacity nodules: fifty-case experience. J Thorac Cardiovasc Surg. 2005;129:991–6.PubMedCrossRef Yoshida J, Nagai K, Yokose T, et al. Limited resection trial of pulmonary ground-glass opacity nodules: fifty-case experience. J Thorac Cardiovasc Surg. 2005;129:991–6.PubMedCrossRef
36.
Zurück zum Zitat Yamato Y, Tsuchida M, Watanabe T, et al. Early results of a prospective study of limited resection for bronchioloalveolar adenocarcinoma of the lung. Ann Thorac Surg. 2001;71:971–4.PubMedCrossRef Yamato Y, Tsuchida M, Watanabe T, et al. Early results of a prospective study of limited resection for bronchioloalveolar adenocarcinoma of the lung. Ann Thorac Surg. 2001;71:971–4.PubMedCrossRef
37.
Zurück zum Zitat Nakata M, Sawada S, Yamashita M, et al. Objective radiologic analysis of ground-glass opacity aimed at curative limited resection for small peripheral non-small cell lung cancer. J Thorac Cardiovasc Surg. 2005;129:1226–31.PubMedCrossRef Nakata M, Sawada S, Yamashita M, et al. Objective radiologic analysis of ground-glass opacity aimed at curative limited resection for small peripheral non-small cell lung cancer. J Thorac Cardiovasc Surg. 2005;129:1226–31.PubMedCrossRef
38.
Zurück zum Zitat Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Ann Thorac Surg. 1995;60:615–23.CrossRef Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Ann Thorac Surg. 1995;60:615–23.CrossRef
39.
Zurück zum Zitat Kondo D, Yamada K, Kitayama Y, et al. Peripheral lung adenocarcinomas: 10 mm or less in diameter. Ann Thorac Surg. 2003;76:350–5.PubMedCrossRef Kondo D, Yamada K, Kitayama Y, et al. Peripheral lung adenocarcinomas: 10 mm or less in diameter. Ann Thorac Surg. 2003;76:350–5.PubMedCrossRef
40.
Zurück zum Zitat Ikeda N, Maeda J, Yashima K, et al. A clinicopathological study of resected adenocacinoma 2 cm of less in diameter. Ann Thorac Surg. 2004;78:1011–6.PubMedCrossRef Ikeda N, Maeda J, Yashima K, et al. A clinicopathological study of resected adenocacinoma 2 cm of less in diameter. Ann Thorac Surg. 2004;78:1011–6.PubMedCrossRef
41.
Zurück zum Zitat Inoue M, Minami M, Shiono H, et al. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement. J Thorac Cardiovasc Surg. 2006;131:988–93.PubMedCrossRef Inoue M, Minami M, Shiono H, et al. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement. J Thorac Cardiovasc Surg. 2006;131:988–93.PubMedCrossRef
42.
Zurück zum Zitat Fukui T, Katayama T, Ito S, et al. Clinicopathological features of small-sized non-small cell lung cancer with mediastinal lymph node metastasis. Lung Cancer. 2009;66:309–13.PubMedCrossRef Fukui T, Katayama T, Ito S, et al. Clinicopathological features of small-sized non-small cell lung cancer with mediastinal lymph node metastasis. Lung Cancer. 2009;66:309–13.PubMedCrossRef
Metadaten
Titel
A clinicopathological study of resected non-small cell lung cancers 2 cm or less in diameter: a prognostic assessment
verfasst von
Chun-Lei Shi
Xue-Yan Zhang
Bao-Hui Han
Wei-Zhong He
Jie Shen
Tian-Qing Chu
Publikationsdatum
01.12.2011
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 4/2011
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-010-9632-y

Weitere Artikel der Ausgabe 4/2011

Medical Oncology 4/2011 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.